Skip to main content
NCD 280.13 · version 3

NCD 280.13: Transcutaneous Electrical Nerve Stimulators (TENS) - RETIRED

QuickIntell editorial content · Legacy registry date · Review not verified

Data effective
Data currency: Medicare Coverage Database release of September 24, 2026 (effective September 20, 2026). Next CMS release: weekly (every Thursday) for the MCD; quarterly for lab NCD code lists.

Key facts for NCD 280.13

Benefit category
Durable Medical Equipment
Effective date
04/10/2023
Implemented 04/10/2023
Transmittal
Transmittal 11892
Versions published
3
Manual chapter
280
NCD Manual (Pub. 100-03)

TL;DR

NCD 280.13 sets Medicare's national policy for transcutaneous electrical nerve stimulators (tens) - retired under the benefit category "Durable Medical Equipment", effective 04/10/2023 and implemented 04/10/2023. 280.13 - Transcutaneous Electrical Nerve Stimulators (TENS) (RETIRED) It has been revised 2 times since publication and binds every Medicare Administrative Contractor nationally.

Indications and limitations of coverage

280.13 - Transcutaneous Electrical Nerve Stimulators (TENS) (RETIRED)

(Rev. 11892; Issued: 03-09-23; Effective: 04-10-23; Implementation: 04-10-23)

Please note section 280.13 has been removed from the NCD Manual and incorporated into NCD 160.27 effective June 8, 2012.

Text reproduced from the CMS Medicare Coverage Database record for NCD 280.13 version 3. View the original on cms.gov.

Revision history

11/2012 - (Rev.149, Issued: 11-30-12, Effective: 06-08-12, Implementation: 01-07-13)

07/1995 - Provided coverage of TENS under the DME benefit. Effective date 08/07/1995. (TN 78)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

How QuickIntell applies NCD 280.13

QuickAuth checks the ordered service and diagnosis against NCD and LCD criteria before the encounter, QuickCode validates the diagnosis pairing on the claim, and QuickRCM routes CARC 50 denials with the policy text and the covered-code list attached so the appeal starts with evidence.

Frequently asked questions — NCD 280.13

What does NCD 280.13 cover?

280.13 - Transcutaneous Electrical Nerve Stimulators (TENS) (RETIRED) The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 280.13 take effect?

The current version (3) is effective 04/10/2023, implemented 04/10/2023, published in transmittal 11892. CMS lists 3 versions of this NCD.

Does a Local Coverage Determination override NCD 280.13?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.